April 2011

BioRegenerative Sciences, Inc., a privately owned stem cell therapeutics corporation headquartered in San Diego, CA, USA, announced today the release of BRS’s human hair regrowth product for women, called Hair Stemulating Complex for Women.

Clinical trials in men and women have shown significant hair growth within 4-6 weeks following the daily application of the stem cell-based formulation.

Dr. Greg Maguire, CEO of BioRegenerative Sciences, said “HSC is formulated using BRS’s core technology where the molecules from multiple stem cell types are used to mimic the natural healing and growth processes of the human body.

Our S2RM TechnologyTM nourishes the scalp’s stem cell niche where the hair and the hair’s pigmentation develop.”

Dr. Rita Friedman, a member of BRS’ Scientific Advisory Board, added “For the millions of men and women who struggle with their hair loss, the results of our HSC trial indicate the potential for a highly effective treatment option that stimulates growth of new hairs along with increasing the thickness of existing hairs, doing so with increased natural pigmentation of the hair.

BRS’ new product called HSC represents a non-invasive and effective shift from conventional treatment options to one that can promote the growth of new or dormant hairs using the body's own naturally occurring regenerative mechanisms.”

Of the over 87 million people in the United States who suffer from hair loss, estimates suggest that only 2-7% seek surgical or pharmacological treatment.

These data are true world-wide because of the lack of effective medical options for this widespread condition.

Hair Stemulating Complex from BioRegenerative Sciences is a new, non-invasive, and effective means for treating hair loss.

Launch of Hair Stemulating Complex for Men is expected 3rd quarter 2011.

Source

Effects of menopause on hair

Potential Baldness Treatment?

Hair loss news